Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Rhea-AI Summary

Pfizer Inc. (NYSE: PFE) announces a webcast featuring key executives, including Chief Scientific Officer Mikael Dolsten, on November 17, 2021, at 12:30 p.m. EST during the Wolfe Research Healthcare Conference 2021. The session will cover advances in research and development, with a focus on their product pipeline.

Investors can access the live webcast and later replay on Pfizer's investor website, with transcripts available within 24 hours. Pfizer continues to emphasize its commitment to innovative healthcare solutions and improving patient lives globally.

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Mikael Dolsten, Chief Scientific Officer, President, Worldwide Research, Development and Medical; Annaliesa Anderson, Vice President and Chief Scientific Officer, Bacterial Vaccines and Hospital; and Charlotte Allerton, Senior Vice President and Head of Medicine Design, at the Wolfe Research Healthcare Conference 2021 on Wednesday, November 17, 2021 at 12:30 p.m. Eastern Standard Time.

To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.

The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; and our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and our investigational protease inhibitors, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005220/en/

Media Contact:

PfizerMediaRelations@Pfizer.com

+1 (212) 733-1226

Investor Contact:

IR@Pfizer.com

+1 (212) 733-4848

Source: Pfizer Inc.

FAQ

What is the date and time of the Pfizer webcast at the Wolfe Research Healthcare Conference 2021?

The Pfizer webcast will take place on November 17, 2021, at 12:30 p.m. EST.

Who will represent Pfizer during the Wolfe Research Healthcare Conference 2021?

Mikael Dolsten, Annaliesa Anderson, and Charlotte Allerton will represent Pfizer.

How can I access the Pfizer webcast for the Wolfe Research Healthcare Conference?

The webcast can be accessed at www.pfizer.com/investors.

Will there be a replay of the Pfizer webcast available?

Yes, the transcript and replay will be available on Pfizer's investor website within 24 hours.

What is the stock symbol for Pfizer?

The stock symbol for Pfizer is PFE.